Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: A double-blind, randomized controlled phase 1/2 trial
International Journal of Infectious Diseases (2021) - Comments
pubmed: 34688944  doi: 10.1016/j.ijid.2021.10.030  issn: 1201-9712  issn: 1878-3511 

Michiko Asano, Hiroshi Okada, Yohji Itoh, Hajime Hirata, Kensuke Ishikawa, Erika Yoshida, Akiko Matsui, Elizabeth J. Kelly, Kathryn Shoemaker, Urban Olsson, Johan Vekemans